Ascitic non-HDL-C/HDL-C ratio:a novel prognostic marker in liver cirrhosis
Esawy, M., Shabana, M., Abd elbaser, E., Elsadek, H. (2020). Ascitic non-HDL-C/HDL-C ratio:a novel prognostic marker in liver cirrhosis. EKB Journal Management System, 10(1), 1-9. doi: 10.21608/aeji.2019.18845.1039
Marwa M Esawy; Marwa A Shabana; Elsayed S Abd elbaser; Hany M Elsadek. "Ascitic non-HDL-C/HDL-C ratio:a novel prognostic marker in liver cirrhosis". EKB Journal Management System, 10, 1, 2020, 1-9. doi: 10.21608/aeji.2019.18845.1039
Esawy, M., Shabana, M., Abd elbaser, E., Elsadek, H. (2020). 'Ascitic non-HDL-C/HDL-C ratio:a novel prognostic marker in liver cirrhosis', EKB Journal Management System, 10(1), pp. 1-9. doi: 10.21608/aeji.2019.18845.1039
Esawy, M., Shabana, M., Abd elbaser, E., Elsadek, H. Ascitic non-HDL-C/HDL-C ratio:a novel prognostic marker in liver cirrhosis. EKB Journal Management System, 2020; 10(1): 1-9. doi: 10.21608/aeji.2019.18845.1039

Ascitic non-HDL-C/HDL-C ratio:a novel prognostic marker in liver cirrhosis

Afro-Egyptian Journal of Infectious and Endemic Diseases
Article 1, Volume 10, Issue 1, March 2020, Page 1-9  XML PDF (499.68 K)
Document Type: Original Article
DOI: 10.21608/aeji.2019.18845.1039
View on SCiNiTO View on SCiNiTO
Authors
Marwa M Esawy1; Marwa A Shabana1; Elsayed S Abd elbaser email orcid 2; Hany M Elsadek3
1Clinical Pathology Department, Faculty of Medicine, Zagazig University, Egypt
2Tropical Medicine Department, Faculty of Medicine, Zagazig University, Egypt
3Internal Medicine Department ,Faculty of Medicine , Zagazig University,Egypt
Abstract
Background and study aim: Laboratory tests were developed on ascitic fluid for assessing causes, mechanisms, and prognosis of the diseases. This study aimed to evaluate the prognostic value of ascitic lipids in cirrhosis with special consideration to the non-high-density lipoprotein cholesterol (HDL-C) and its related ratios.
Methods: This cross-sectional study included 120 cirrhotic patients with ascites. Ascitic fluid analysis for lipid contents and calculations of ratios were done. Ascitic lipid contents and ratios are used to assess liver disease severity and predict the mortality in different Child-Pugh groups.
Results: Regarding Child-Pugh score, ascitic cholesterol, and HDL-C showed significantly higher levels in group C when compared to groups A and B.  Ascitic non-HDL-C and ascitic non-HDL-C/ HDL-C ratio had a statistically significant increasing trend among Child-Pugh groups. Serum-ascites cholesterol gradient showed no significant difference among Child-Pugh groups (p>0.05). Ascitic non-HDL-C/ HDL-C ratio had the highest positive linear correlation with cirrhosis severity scores (p<0.0001). High ascitic non-HDL-C/ HDL-C ratio patients had a higher mortality rate when compared to those with a lower ratio (38.5% versus 9.5%).
Conclusion: Ascitic non-HDL-C/HDL-C ratio was more beneficial than non-HDL-C in cirrhosis severity prediction. Also, it could predict the cirrhotic patients' survival. So, Ascitic non-HDL-C/HDL-C ratio seems to be an excellent prognostic marker for cirrhosis.
Keywords
ascites; Lipid; Liver cirrhosis; Non-HDL
Statistics
Article View: 437
PDF Download: 607